Methyltransferase pharmacogenetics

Pharmacology & Therapeutics
R M Weinshilboum

Abstract

No abstract listed.

References

Sep 15, 1979·Clinica Chimica Acta; International Journal of Clinical Chemistry·R M WeinshilboumS Klumpp
Jan 20, 1975·Clinica Chimica Acta; International Journal of Clinical Chemistry·F A Raymond, R M Weinshilboum
Oct 1, 1977·Neuropharmacology·R Weinshilboum, F Raymond
May 2, 1978·Clinica Chimica Acta; International Journal of Clinical Chemistry·R M WeinshilboumP A Pazmiño
Oct 16, 1978·Clinica Chimica Acta; International Journal of Clinical Chemistry·P A Pazmiño, R M Weinshilboum
May 1, 1976·The British Journal of Psychiatry : the Journal of Mental Science·L GrunhausW Jonas
Jan 1, 1988·Genetic Epidemiology·R A PriceR M Weinshilboum
Mar 1, 1988·Clinical Pharmacology and Therapeutics·M C ScottR M Weinshilboum
Mar 1, 1985·Clinical Pharmacology and Therapeutics·N R CampbellR M Weinshilboum
Jul 15, 1985·Clinica Chimica Acta; International Journal of Clinical Chemistry·J A Van LoonR M Weinshilboum
Jul 9, 1968·Biochimica Et Biophysica Acta·J Axelrod, J Daly
Oct 1, 1983·British Journal of Clinical Pharmacology·L LennardJ L Maddocks
Oct 1, 1984·American Journal of Medical Genetics·R M SiervogelR C Elston
Oct 1, 1983·Clinical Pharmacology and Therapeutics·R A KeithR M Weinshilboum
Mar 1, 1983·Biochemical Pharmacology·L C Woodson, R M Weinshilboum
Jan 1, 1982·Journal of Psychiatric Research·A M ReveleyM Sandler
Aug 1, 1982·Biochemical Genetics·J A Van Loon, R M Weinshilboum
May 1, 1981·Clinical Genetics·Y Floderus, L Wetterberg
Jan 1, 1981·American Journal of Medical Genetics·R S Spielman, R M Weinshilboum
Dec 1, 1981·Biochemical Genetics·S Sladek-Chelgren, R M Weinshilboum
Aug 1, 1980·Clinical Pharmacology and Therapeutics·D K ReillyD Van Dyke
Mar 7, 1959·Nature·D D BROWNR TOMCHICK
Sep 1, 1981·Biochemical Pharmacology·Y FloderusL Wetterberg

❮ Previous
Next ❯

Citations

Feb 1, 1992·Journal of Clinical Pharmacology·R J Guttendorf, P J Wedlund
Jan 1, 1991·Cancer Chemotherapy and Pharmacology·E RakaszO Csuka
Jun 15, 2006·Digestive Diseases and Sciences·Albert J Czaja, Herschel A Carpenter
Jan 31, 1990·Clinica Chimica Acta; International Journal of Clinical Chemistry·J RiniR M Weinshilboum
Feb 1, 1993·Pharmacology & Therapeutics·A K DalyJ R Idle
Dec 7, 1995·European Journal of Pharmacology·M VahterA T Natarajan
Apr 13, 2000·Pharmacology & Therapeutics·K Nakagawa, T Ishizaki
Jun 1, 1991·British Journal of Clinical Pharmacology·A TemelliniG M Pacifici
Jan 1, 1993·Pharmacology & Toxicology·H E PoulsenK Wassermann
Oct 17, 2006·Clinical Microbiology Reviews·Joseph MeletiadisThomas J Walsh
May 20, 1999·Annual Review of Pharmacology and Toxicology·R M WeinshilboumC L Szumlanski
May 25, 2010·Journal of Nutritional Science and Vitaminology·Kazuo YamadaMikako Tsuchiya
Jul 1, 1995·Environmental Health Perspectives·P Mushak, A F Crocetti
Jan 1, 1995·Genetic Epidemiology·J P VuchetichR A Price
Sep 5, 2003·Journal of Clinical Pharmacology·Richard Judson
Mar 7, 2014·British Journal of Clinical Pharmacology·Anastasia KonidariWael El-Matary
Jul 29, 2011·Annals of the New York Academy of Sciences·Myunggi BaikLothar Hennighausen
Aug 18, 1992·Biochemical Pharmacology·J A Van LoonR M Weinshilboum
Feb 18, 2003·Fundamental & Clinical Pharmacology·A K Daly
Jan 1, 1993·Drug Metabolism Reviews·S A WrightonJ R Cashman
Sep 1, 1992·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·R M Weinshilboum
Jun 1, 1993·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·T A GlauserR M Weinshilboum
Apr 1, 1991·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·J S HernándezR M Weinshilboum
Jul 13, 2002·Expert Review of Anticancer Therapy·A K Daly, A G Hall
Nov 8, 2007·The Annals of Pharmacotherapy·Milo Gibaldi
Jul 19, 2013·Inflammatory Bowel Diseases·Seymour KatzDarrell S Pardi
Jul 1, 1996·Clinical Pharmacology and Therapeutics·J O Park-HahJ Aarbakke
Jul 1, 1997·Clinical Pharmacology and Therapeutics·D OtternessR Weinshilboum
Jul 18, 2002·Nature Reviews. Drug Discovery·Dan M Roden, Alfred L George
Apr 16, 2014·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Miho KazuiAtsushi Kurihara
Feb 24, 2001·Journal of Hypertension·S T TurnerE Boerwinkle
Jan 1, 1992·The Annals of Pharmacotherapy·M Gibaldi
Dec 16, 1998·The Journal of Biological Chemistry·M A Thompson, R M Weinshilboum
Sep 26, 1997·Chemical Research in Toxicology·N CastagnoliK P Castagnoli

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.